Variant report
Variant | nsv601124 |
---|---|
Chromosome Location | chr6:23466670-23506490 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:2)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:2 , 50 per page) page:
1
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs199004 | chr6:23466670-23466671 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs547267495 | chr6:23466736-23466737 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs571872841 | chr6:23466765-23466766 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs539206622 | chr6:23466782-23466783 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs557286353 | chr6:23466794-23466795 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs16887592 | chr6:23466800-23466801 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
7 | rs536747102 | chr6:23466821-23466822 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs189719726 | chr6:23466829-23466830 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs573271496 | chr6:23466893-23466894 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs540298586 | chr6:23466906-23466907 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs182664289 | chr6:23466908-23466909 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs374335790 | chr6:23466910-23466911 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs577080614 | chr6:23466945-23466946 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs544368495 | chr6:23466994-23466995 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs562547587 | chr6:23467008-23467009 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs528974609 | chr6:23467022-23467023 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs186437051 | chr6:23467050-23467051 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs559859851 | chr6:23467078-23467079 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs527270998 | chr6:23467105-23467106 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs574140973 | chr6:23467109-23467110 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs557211087 | chr6:23467115-23467116 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs191630245 | chr6:23467127-23467128 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs74584697 | chr6:23467130-23467131 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs191335674 | chr6:23467156-23467157 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs532715857 | chr6:23467169-23467170 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs542365256 | chr6:23467197-23467198 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs148056425 | chr6:23467205-23467206 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs141804166 | chr6:23467237-23467238 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs555079472 | chr6:23467249-23467250 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs369126650 | chr6:23467256-23467257 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs183650066 | chr6:23467269-23467270 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs534164617 | chr6:23467284-23467285 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs543337102 | chr6:23467289-23467290 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs558704909 | chr6:23467350-23467351 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs577022865 | chr6:23467358-23467359 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs558668736 | chr6:23467387-23467388 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs377256680 | chr6:23467392-23467393 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs151197810 | chr6:23467399-23467400 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs544191844 | chr6:23467411-23467412 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs187212727 | chr6:23467412-23467413 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs556076692 | chr6:23467449-23467450 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs559131824 | chr6:23467452-23467453 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs150555615 | chr6:23467509-23467510 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs559798415 | chr6:23467605-23467606 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs192132708 | chr6:23467621-23467622 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs561503582 | chr6:23467672-23467673 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs138690482 | chr6:23467696-23467697 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs563927956 | chr6:23467702-23467703 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs183109205 | chr6:23467706-23467707 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs576566658 | chr6:23467728-23467729 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Cancer | 20164920 | CNVD |
Colorectal cancer | 21297112 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Follicular lymphoma | 20505157 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Leukemia | 21518781 | CNVD |
Cancer | 21637783 | CNVD |
Facial dysmorphism | 22105932 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Diffuse large b-cell lymphoma | 18287131 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Breast cancer | 21264507 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Cancer | 16751803 | CNVD |
Bladder cancer | 19088036 | CNVD |
Wilms tumour | 21544195 | CNVD |
Uveal melanoma | 21693616 | CNVD |
Biliary cancer | 19435499 | CNVD |
Malaria | 21533027 | CNVD |
Retinoblastoma | 19183342 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Lung cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Prostate cancer | 18632612 | CNVD |
Myelodysplastic syndrome | 21251322 | CNVD |
Breast cancer | 21858162 | CNVD |
Lung cancer | 18438408 | CNVD |
Multiple myeloma | 17550852 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Gastric cancer | 16891809 | CNVD |
Ovarian cancer | 21781307 | CNVD |
Autism | 21448237 | CNVD |
Cancer | 20164919 | CNVD |
Melanoma | 18172304 | CNVD |
Invasive pancreatic ductal carcinoma | 16982739 | CNVD |
Breast cancer | 22844521 | CNVD |
HIV/AIDS | 22844521 | CNVD |
Ovarian cancer | 22844521 | CNVD |
Prostate cancer | 22844521 | CNVD |
Psoriasis | 22844521 | CNVD |
Rheumatoid arthritis | 22844521 | CNVD |
Sclerosis systemic | 22844521 | CNVD |
Systemic lupus erythematosus | 22844521 | CNVD |
Breast cancer | 22522925 | CNVD |
Breast cancer | 21552322 | CNVD |
Immune disease | 21076436 | CNVD |
Autoimmune disease | 19135723 | CNVD |
Systemic lupus erythematosus | 17953491 | CNVD |
Recurrent Infections | 22737222 | CNVD |
Systemic lupus erythematosus | 21904924 | CNVD |
Ependymoma | 19289631 | CNVD |
Gestational infection | 22844521 | CNVD |
Head circumference | 22844521 | CNVD |
Infertility | 22844521 | CNVD |
Recurrent birth weight diabetes | 22844521 | CNVD |
Obesity | 22844521 | CNVD |
Recurrent pregnancy loss | 22844521 | CNVD |
Intellectual disability | 21811512 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Congenital anomalies of the kidney and urinary tract | 18694510 | CNVD |
Nasopharyngeal cancer | 22815911 | CNVD |
Osteosarcoma | 16790693 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Basal cell lymphoma | 21115979 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Ovarian cancer | 21720365 | CNVD |
Breast cancer | 17133270 | CNVD |
Autism | 22495311 | CNVD |
Burkitt''s lymphoma | 19759907 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Cancer | 16790693 | CNVD |
Breast cancer | 22032731 | CNVD |
Cervical cancer | 21062161 | CNVD |
Breast cancer | 21785460 | CNVD |
Bladder cancer | 16790693 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Retinoblastoma | 16790693 | CNVD |
Esophageal adenocarcinoma | 18820669 | CNVD |
Systemic lupus erythematosus | 17503323 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Urothelial cell carcinoma | 18451213 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Ovarian cancer | 20844748 | CNVD |
Developmental delay | 19490664 | CNVD |
T-cell lymphomas | 19863542 | CNVD |
Urothelial carcinoma | 18382360 | CNVD |
Lung cancer | 19153074 | CNVD |
Breast cancer | 21364760 | CNVD |
Cancer | 21183584 | CNVD |
Tetralogy of Fallot | 22912587 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Non-syndromic sensorineural hearing loss | 22037309 | CNVD |
Williams-beuren syndrome | 16971481 | CNVD |
Uveal melanoma | 20484589 | CNVD |
Non-syndromic sensorineural hearing loss | 21293372 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr6:23466400-23467800 | Enhancers | Fetal Brain Male | brain |
2 | chr6:23478200-23479200 | Enhancers | HUES64 Cell Line | embryonic stem cell |
3 | chr6:23478600-23479000 | Enhancers | ES-UCSF4 Cell Line | embryonic stem cell |
4 | chr6:23479200-23479800 | Enhancers | Primary neutrophils fromperipheralblood | blood |
5 | chr6:23479800-23480800 | Weak transcription | Primary neutrophils fromperipheralblood | blood |
6 | chr6:23480800-23484200 | Enhancers | Primary neutrophils fromperipheralblood | blood |
7 | chr6:23483800-23484400 | Enhancers | Foreskin Keratinocyte Primary Cells skin03 | Skin |
8 | chr6:23484200-23489200 | Weak transcription | Primary neutrophils fromperipheralblood | blood |
9 | chr6:23489200-23490200 | Enhancers | Primary neutrophils fromperipheralblood | blood |
10 | chr6:23493000-23493200 | Enhancers | Brain Germinal Matrix | brain |
11 | chr6:23493200-23494200 | Weak transcription | Brain Germinal Matrix | brain |
12 | chr6:23494200-23495400 | Enhancers | Brain Germinal Matrix | brain |
13 | chr6:23496000-23496200 | Enhancers | Fetal Lung | lung |
14 | chr6:23496000-23496400 | Enhancers | HUES6 Cell Line | embryonic stem cell |
15 | chr6:23497800-23498600 | Enhancers | Fetal Heart | heart |
16 | chr6:23497800-23498600 | Enhancers | Right Ventricle | heart |
17 | chr6:23498000-23498800 | Enhancers | Bone Marrow Derived Cultured Mesenchymal Stem Cells | Bone marrow |
18 | chr6:23498000-23499600 | Enhancers | Primary hematopoietic stem cells G-CSF-mobilized Female | -- |
19 | chr6:23498000-23499600 | Enhancers | Fetal Lung | lung |
20 | chr6:23498200-23498600 | Enhancers | Fetal Muscle Leg | muscle |
21 | chr6:23498800-23499200 | Enhancers | Primary hematopoietic stem cells | blood |